Renal failure is the most crippling condition in patients with the renal illness. Not exclusively does it cause huge dismalness, however, it additionally has a high mortality. Examination of progress depending on the investigation of the corresponding serum creatinine against time plots, demonstrates it to be direct in most patients. This has persuaded that the progress to end-stage renal failure is the inescapable the outcome of the losing of a basic measure of useful renal tissue and the versatile changes that occur in excess nephrons [1].

Glomerulonephritis was the one of the main reasons for kidney sickness quite a few years prior. These days, in western countries contaminations considered not a significant reason for renal diseases. Additionally, recent proof showed that overall diabetes and hypertension are significant reasons for renal diseases. In a CKD patient which have high risk of end stage renal failure, require dialysis or renal transplant in order for running and long-distance walking [2]. The worldwide assessed predominance of CKD is 13.4% and patients of end stage kidney disease (ESKD) [3, 39]. In view of the expenses and the intricacy of its treatment, not very many patients can acquire satisfactory treatment and CRF places a weighty monetary trouble on any general public [4].

Albuminuria shows kidney harm in many renal infections. GFR can be assessed from aligned serum creatinine and assessing conditions like diet modification. Kidney infection seriousness is grouped into five phases as indicated by the degree of GFR. Kidney sickness. [5].

The rate and predominance of end-stage kidney sickness differ generously across nations and areas. Over 80% of all patients getting end-stage kidney sickness treatment are assessed to be in affluent nations with huge older populaces furthermore, widespread admittance to wellbeing care. Projected overall populace changes propose that the likely number of instances of end-stage kidney illness will build dis proportionately in non-industrial nations, like China or India, where the quantities of older individuals are extending. This effect will be improved further if the patterns of expanding hypertension and diabetes prevalence endure, contending reasons for death like stroke and cardiovascular sicknesses are decreased, and admittance to therapy improves [6, 12]. Chronic renal failure rate increased dramatically in individuals above the age of 49, with half of the patients being 70 or older. When the incidence per million at risk in each age group is computed, the increase is even more striking. The incidence climbed from 60 per million per year to 282 per million per year among people of age of 20 to 49 year. The relevance of accurate identification of the etiology of renal failure lies mostly in identification and treatment of reversible causes. It also aids in determining prognosis and RRT planning, determining the risk of primary renal disease recurrence following renal transplantation, and counseling families with family diseases like vesico-ureteric reflux, polycystic kidney disease, or AL port’s syndrome [5].

Renal Hypertension

The most notable distinction between the US and the UK is the apparent prevalence of kidney diseases due to hypertension, which appears to be significantly higher in the US. This exemplifies the inaccuracy of diagnosis. Although many individuals with hypertensive renal illness are diagnosed based on clinical criteria rather than biopsy, many European biopsy investigations have revealed that many of these patients have other renal disease [4].

Diabetic Nephropathy

It is the most prevalent cause of ESRF in industrialized nations, United States 46%, Japan 41%, New Zealand 40%, Germany 34%, Australia 30% and United Kingdom 18%. This disparity is likely due to both differences in the prevalence of diabetes and differences in physicians' willingness to give dialysis to diabetic patients with numerous comorbidition [7].

The diabetic ESRF population is aging, with diabetics type II outnumbering type I diabetics by more than ten to one in some nations

Glomerulonephritis

CRF develops in several types of glomerulonephritis. Despite recent improvements in finding the hidden processes of illness, only some types of glomerulonephritis had proven to react to presently available treatments in controlled studies [8].

Crf Can Also Be Caused By a Number of Other Factors

It's critical to rule out less prevalent but potentially reversible CRF causes. The bulk of them aren't linked to excessive proteinuria. Reno vascular disease, renal vasculitis and other medication responses, NSAIDs, and acute interstitial nephritis, all of which can be treated well with prompt identification. The most prevalent cause of renal impairment is prostatic illness in older men, therefore obstructive uropathy should always be evaluated [9, 40].

The objective of dialysis therapy is to save a life that might otherwise be lost. The reduction of significant morbidity for surviving patients, whether owing to therapy or illness, is a logical result and essential extension of that goal. A desired objective would be to reduce or eliminate the less severe symptoms of illness and treatment consequences that are bothersome. Finally, once those objectives are met, the therapy should have as little impact on the patient's personal and social life as feasible. Type of dialysis mostly used for treatment option (10]

Hemodialysis

Solute diffusion occurs during hemodialysis. When solutions of dialysis and blood are combined the elimination of waste and the replenishing of bodily buffers occurs. Heparinized blood is a kind of blood that has been treated with anticoagulants. Plastic dialyzer is used to push water to eliminate waste products at flow rates of 300-500 ml/minute. During 3 to 4 hours of session, there is 65 to 70% drop in urea. By modulating the Trans membrane pressure across the dialyzer, fluid extraction from the plasma into the dialysate can be accurately controlled (11].

Difficulties with Hemodialysis

The most occurring side effect of dialysis is hypotension. The most frequent cause is volume depletion brought on by ultrafiltration, while other factors might also be involved. It's interesting to note that certain hypotensive individuals undergo paradoxical reflex sympathetic nervous system withdrawal during dialysis. This result in decreasing heart rate, drop in vascular resistance, and falling of blood pressure [6, 12]. In addition to ultrafiltration, hypotension may also be brought on by the dialysis process. In addition to the extracellular volume reduction brought on by osmolar changes, other factors are crucial. Dialysis at 37°C, for example, has been linked to excessive heat retention in some individuals, which might induce vasodilation and decrease blood pressure. Increased peripheral vascular resistance, elevated plasma norepinephrine levels, better cardiac contractility, and stable blood pressure are all effects when we did dialysis at 35°C. It is important to detect the potential causes of hypotensive episodes. By lowering ultrafiltration rates, giving IV saline, or doing both, most cases of hypotension can be resolved [13].

Technical failures, reactions to drugs administered, and morbidity connected to dialysis could all be made worse. When utilizing a new dialyzer for the first time, symptoms including nausea, hypotension, difficulty breathing, discomfort in the chest and back can occur. The higher prevalence of this first-use problem in cellulose membranes is assumed to be related to increased complement activation. Hypersensitivity reactions may be brought on by adverse reactions to the ethylene oxide that used to sterilise the dialyzer as well as unfavourable reactions to the particular membrane material poly acrylonitrile [14].The most frequent ACE inhibitor reactions are those involving poly acrylonitrile. Bradykinin-producing enzymes are stabilized by the membranes exceptionally high negative surface charge when blood comes into contact with it. Bradykinin is quickly degraded by kinases in normal circumstances; however, ACE inhibitors stop this process, which can cause severe hypotension. On rare occasions, patients on ACE inhibitors who get dialysis with other membranes have experienced comparable reactions [15].

Peritoneal Dialysis

Owing to its simplicity of its use, peritoneal dialysis has gained appeal on a worldwide scale. A peritoneal dialysis programme is used by dialysis patients in Mexico 91%, the United Kingdom 50%, and Canada 38%, and 16% in United States. The peritoneal cavity is typically opened up, and a plastic catheter is introduced and placed in the subcutaneous tissues. A dialysis solution is injected into the peritoneal cavity through the catheter, where it stays for several hours. Physiologic concentrations of sodium, calcium, magnesium, and (typically) lactate are present in this solution as a buffer [16]. During this time, diffuse solute transfer occurs across the peritoneal membrane until fresh fluid is substituted for the old. An osmolar gradient is produced by adding glucose to the dialysate at concentrations ranging between 1.5 to 4.25 percent, which enables fluid to be ultra-filtered. Net ultrafiltration is restricted by the diaphragmatic lymphatics, which take up about 1 mL of peritoneal fluid each minute [3].

Peritoneal Dialysis Complications

The most frequent severe peritoneal dialysis consequence is peritonitis. Patients present with fever, stomach pain, and a hazy peritoneal dialysate with more than 100 white cells and a content of polymorph nuclear leukocytes of more than 50%. Gram's staining only identifies organisms in 10 to 40% of cases, but it can help diagnose gram-negative or fungal peritonitis early. Peritonitis is less common because to recent advances in dialysis tubing, but it still happens around once per 15 patient-months of dialysis. Black patients have a greater risk of peritonitis than other populations for unknown causes. Gram-positive cocci are the most prevalent cause of peritonitis, followed by gram-negative rods. Vancomycin and third-generation cephalosporin are frequently employed in empirical regimens up to a specific organism can be targeted. First-generation cephalosporin-based regimens are being reemphasized since vancomycin-resistant enterococci are becoming more prevalent [17].

The current standard of care for peritonitis associated with peritonea is an aminoglycoside plus cefazolin or cephalothin. The local bacteriology of the peritonitis must also be taken into consideration while choosing the best course of action. Most antibiotics reach acceptable blood levels when administered intraperitoneally, and the introduction of heparin stops the development of fibrin till the liquid is clear. If the peritonitis is chronic or recurrent, the catheter must be taken out [18]. Most episodes of peritonitis typically have no impact on the peritoneal membrane's effectiveness. Although fluconazole and flu cytosine together may help some patients, yeast peritonitis frequently necessitates catheter removal. Treatment options for infections at the dialysis catheter exit site and in the subcutaneous tunnel include oral antibiotics and local treatment, but catheter must be removed for the majority of tunnel infections. When aseptic procedure is broken, infected exit sites and nasal carriage of bacteria like Staphylococcus aureus act as reservoirs of infections that could end up causing peritonitis. Hematogenous seeding of the pleural cavity and bacterial transmission through the catheter tube, across the intestinal lining, or via the female reproductive system are additional causes of peritonitis. Other issues include glucose absorption, which can cause hypertriglyceridemia or weight gain, and amino acid and albumin losses (5 to 15 g per day). Dialysis patients with diabetes can inject insulin along with the dialysate for highly strict blood sugar management. A disproportionately high glucose concentration denotes pleural fluid leaking after dialysis [19].

Patients who have active gastrointestinal conditions as well as those who have mechanical problems that interfere with peritoneal dialysis, may choose to explore hemodialysis. Patients whose peritoneal dialysis is insufficient, such as those who are large, have low peritoneal clearance, or have experienced peritonitis associated with peritoneal dialysis, may need hemodialysis. Additionally, hemodialysis at a dialysis facility is more suitable for people who are unable to complete peritoneal dialysis exchanges or who are hesitant to take charge of their own treatment. Patient's will and the doctor's experience, typically decide the type of dialysis that is employed. [11].

The prevalence of chronic renal disease is becoming a serious public health concern. One strategy to lessen the cost burden of chronic renal illness is early intervention. To do this, we must be able to identify people who are more likely to suffer from renal disease. The genetic and phenotypic makeup of an individual is what causes kidney disease. Significant variables include racial background, gender, age, and family history [20]. Additionally, smoking, obesity, hypertension, and diabetes can all contribute to kidney disease. The progression of end-stage renal disease can happen quickly and readily in a patient with uncontrolled diabetes and hypertension. Risk factors include heavy metals, alcohol abuse, tobacco, analgesic medications, cancer, hepatitis C virus infection, HIV infection, hyperlipidemia and renal injury. Blood creatinine levels and urinalysis are often sufficient for initial screening in people who are at risk for chronic renal disease. [21].

Geneticfactors
Another genetic risk that contributes to chronic renal failure is an APOL1 mutation. An autosomal recessive inheritance pattern is linked with a considerable rise in the risk of ESRD. African Americans are more likely to get CKD than other people because of APOL1 mutations. The renin-angiotensin system genes appear to play a particularly significant impact in CKD. In a study, angiotensinogen, angiotensin-I-converting enzyme, and angiotensin II type 1 receptor polymorphisms were genotyped in 135 patients with CKD and 270 healthy controls. It has been demonstrated that CKD patients exhibit substantial associations between the ACE-A2350G and AGTR1-C573T polymorphisms [22].

Age

As people age, their kidneys no longer perform as well for both men and women. More over half of the older people examined had kidney disease (CKD) stages 3-5 (GFR60 ml/min per 1.73 m2), in accordance with the Kidney Disease Results Quality Initiative (K/DOQI) standards of the National Kidney Foundation. As a result of many renal insults, the elderly are much more susceptible to develop CKD. 12 For Turkish patients older than 30 in the CREDIT study, the risk ratios for CKD ranged from 1.45-2.18 for every decade of age rise [23].

Weight at Birth

Brenner and colleagues proposed that intra - uterine restriction may result in decreasing nephron amount, which would increase the risk of hypertension and kidney disease (Barker hypothesis). It has been shown that this concept is supported by a rise in nephron counts of 257,426 glomeruli per kg gain in birth weight. A reduced overall GFR, a higher urine albumin to creatinine ratio, and decreased nephron numbers all result in intraglomerular hypertension and hyper filtration in the left nephrons [24].

Diabetes Mellitus

In both developed and emerging nations, diabetes mellitus (DM) is the main contributor to ESRD and CKD. The Turkish Society of Nephrology's registry shows that 37.3 percent of hemodialysis patients in Turkey are diabetic. Half of all new ESRD patients in the United States, according to the USRDS, have diabetic nephropathy. Diabetics develop kidney disease as a result of hyper filtration damage, advanced glycosylation end products, and reactive oxygen species [25].

Nephrotoxins

Heavy metal exposure, excessive painkiller usage, alcohol consumption, and recreational drug use have all been linked to the development of CKD. The odds ratio for developing end-stage renal disease (ESRD) who consume 1000–4999 pills was 2 and who took 5000 pills, 2.4 when individuals who had consumed less than 1000 acetaminophen tablets throughout their lifetime were used as the control group [26].

For most individuals with end-stage renal illness, kidney transplantation is the best option. The scarcity of donor organs, on the other hand, continues to be a major impediment to effective, early transplantation. Despite an increase in live family-related and unrelated donors, the scarcity has increased. Allograft and recipient survival, on the other hand, have dramatically improved during the previous ten years. This positive outcome is due to a number of variables, including a more favorable balance between immunosuppressive effectiveness and toxicity. As acute rejection and early graft loss have become less prevalent, more attention is being paid to the prevention and treatment of renal transplant long-term problem [27].

The approaches mentioned above are the most common, however there is a wide range of technical expertise. The donated kidney can be implanted extra-peritoneally or intraperitoneally in the left or right iliac fossa. Alternately, the ureter can be implanted into a gap in the middle of the gut. Depending on the surgical techniques used, radiologists may encounter different imaging appearances and postoperative issues, thus it is important for them to get familiar with these methods. Vascular and urologic issues are frequent and significantly affect morbidity and mortality. 4 to 8 percent of individuals experience urologic issues, compared to 1 to 2 percent who experience vascular issues. Vascular issues include renal vein thrombosis, infarction, arteriovenous fistulas, pseudo aneurysms, and renal artery stenosis. Nonvascular complications include urinary obstruction, fluid collections during, neoplasms, gastrointestinal and herniation issues, and post-transplant lymph proliferative illness. With the advancement of percutaneous diagnostic and interventional techniques, surgical intervention to treat issues can now often be avoided [28].

Most of these patients' long-term care will likely be provided outside of transplant centres as a growing number of transplant patient’s return with functional allografts. To recognize and address transplantation issues, a radiologist from a neighbourhood hospital might be consulted [29].

Collections of Perinephric Fluid

Hematomas, sarcomas, urinomas, lymphoceles, and abscesses are all frequent postoperative fluid collections after transplantation. Although the look of per-transplant fluid collections is hazy, depending on the radiographic appearance of the collection and the time following surgery, an attempt may be made to identify the fluid type. Finally, if percutaneous aspiration of the fluid is required, the diagnosis can be determined. Both a fluid collection's composition and location affect how it looks and how it behaves. Hemorrhage on the other hand, is likely to result in free fluid with little mass impact [30].

Hematomas

Fluid collections that are seen upon transplantation are almost certainly hematomas must be handled as a standard surgical consequence. These collections' size, location, and growth all influence how significant they are. Any such collections should have their size noted on the initial US scan since an increase in size could be the sign for surgery. Abscesses are more complex collections that show clinical symptoms of infection and are found later in the postoperative phase [31].

Urinomas

Urine leaks are a very uncommon complication after transplantation, manifesting as discomfort, edema, and discharge from the incision in the early postoperative period. Leaks at the ureter vesicle anastomosis may be brought on by surgical technique. Ischemia typically results in urine leaks somewhere else in the collecting system, which eventually causes necrosis of the collecting system that either affects the entire ureter or is localised to a limited area. Harvesting the graft, anastomotic method, rejection, vascular supply fluctuation, or medicine can all cause ischemia? Internal septations are less common in urinomas than in hematomas, despite the fact that their appearance on US images is nonspecific. On radionuclide imaging studies, increasing radiotracer activity demonstrate urine [32].

Lymphoceles

Up to 15% of people can develop lymphoceles, which typically present 4–8 weeks after surgery. These aggregates are result of normal lymphatic channels being cut off during peri-vascular dissection. The majority of lymphoceles are discovered accidentally, show no symptoms, and don't need to be treated. However, because of their large size, lymphoceles can create edema in the labia, scrotum, abdominal wall, or leg, which can impair renal function and result in hydronephrosis. On US pictures, a rounded collection at the mid-ureter, which is linked with hydronephrosis, may be detected. In a patient with leg edoema, an ultrasound may reveal compression of the external iliac vein by fluid accumulation, in order to rule out a deep venous thrombosis. A huge photogenic area may be observed on radionuclide imaging exerting a mass impact on the transplant [33].

Men's renal insufficiency progresses more quickly than women's in several studies of chronic renal illness. However, some studies have not found any differences between men and women. Although it is yet unknown if gender has an impact on diabetic renal disease, women with non-diabetic kidney diseases progress more slowly than men do. Sex hormones may alter the renin-angiotensin system, decrease mesangial collagen production, change collagen breakdown, and increase nitric oxide synthesis in order to affect how gender affects chronic renal illness [34].

Gender Dimorphism in the Progression of Renal Disease: Possible Mechanisms

The reasons behind the gender discrepancy in the incidence, prevalence, and progression rate of a variety of renal illnesses are yet unknown. The direct cellular effects of sex hormones, gender differences, glomerular hemodynamics, and renal nutrition are all potential causes. Our understanding of these potential factors has improved thanks to animal studies [35].

The Renal System

Even when body weight is taken into account, male animals have more renal mass and weight as compare to female animals. The causes of this size and weight difference are unknown, although they might be linked to androgens' direct actions, which increase renal weight. The major predictor of kidney size in humans is body surface area. As a result, men's kidneys are bigger than women's. Some human studies show that women have fewer glomeruli than males, however these differences, if existent, have been found to be in the 10% to 15% range [36].

Hemodynamics at the Systemic and Glomerular Levels

The glomerular filtration rate is the same for male and female animals, as well as for men and women, when renal weight and body surface area are considered. The glomerular hemodynamic response to stress may vary between men and women, it is important to note. Males did not increase their glomerular filtration fraction after obtaining infused angiotensin II, but healthy young men did. This finding suggests that men may have a higher glomerular capillary pressure. This study could help to explain why some kidney diseases progress differently in men and women. The glomerular hemodynamic reaction to hyperglycemia has also shown gender-related differences. Studies of hemodynamic response to hyperglycemia shown why women with diabetic kidney disease do not appear to be protected, in contrast to research of hemodynamic response to angiotensin II, shown why women have a good prognosis with renal illness. According to some research, men have higher systemic blood pressures, and according to others, they are more prone to hypertensive kidney impairment. The worse renal prognosis linked with male sex is still noticeable in illnesses like polycystic kidney disease even after blood pressure levels are taken into consideration [37].

Sex Hormones' Direct Effects

Sex hormones have an impact on a variety of cellular functions, including the synthesis of cytokines, growth factors, vasoactive substances, and matrix proteins like angiotensin, nitric oxide (NO), and collagen. Through the oestrogen receptor, estrogens in particular regulate genes involved in the metabolism of the extracellular matrix. Oestrogen enhances the production of angiotensinogen and the angiotensin type 2 receptor while decreasing the production of renin, angiotensin-converting enzyme, and angiotensin II. Prorenin, renin, and plasma renin activity are all higher in male. [38].

Patients with both hypertension and diabetes mellitus had low levels of patient awareness of chronic kidney disease and associated risk factors, according to our study. The prevalence of chronic kidney disease was high, and it was discovered that uncontrolled blood pressure, high fasting blood sugar, long-term hypertension, non-use of ACEIs, and a lack of understanding of CKD were independent predictors of the condition. It is essential to work toward raising patient awareness and conducting routine CKD screenings among high risk groups in order to detect chronic kidney disease at an early stage before it worsens and leads to renal failure.

1. Wight JP, Salzano S, Brown CB, El Nahas AM. Natural history of chronic renal failure: a reappraisal. Nephrol Dial Transplant. 1992; 7: 379-383.
2. Qui-Li Z, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC public health, 2008; 8: 1-13.
3. Lv JC, Zhang LX. Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Me Biol, 2019; 1165: p. 3-15.
4. Hill NR, Samuel TF, Jason LO, Jennifer AH, Daniel SL, Christopher AO, et al. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. 2016; 11: 0158765.
5. Levey AS, Paul Ed, Coresh J, Meguid EN, Brad CA, Kunihiro M, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011; 80: 17-28.
6. Jha V, Guillermo G-G, Kunitoshi I, Zuo L, Saraladevi N, Brett P, et al., Chronic kidney disease: global dimension and perspectives. Lancet. 2013; 382: 260-272.
7. Roomizadeh P, Taheri D, Abedini A, Mortazavi M, Larry M, Mehdikhani B, et al. Limited knowledge of chronic kidney disease and its main risk factors among Iranian community: an appeal for promoting national public health education programs. International journal of health policy and management. 2014; 2: 161-166.
8. Moazzeni SS, Arani RH, Hasheminia M, Tohidi M, Azizi F, Hadaegh F. High incidence of chronic kidney disease among Iranian diabetic adults: using CKD-EPI and MDRD equations for estimated glomerular filtration rate. Diabetes Metab J. 2021; 45: 684-697.
9. Feest T, Mistry CD, Grimes DS, Mallick NP. Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment. Br Med J. 1990; 301: 897.
10. Lowrie EG. Chronic dialysis treatment: Clinical outcome and related processes of care. Am J Kidney Dis. 1994; 24: 255-266.
11. Pastan S, Bailey J. Dialysis therapy. N Engl J Med. 1998; 338: 1428-1437.
12. Jha V, Guillermo G-G, Kunitoshi I, Zuo L, Saraladevi N, Brett P, et al. Chronic kidney disease: Global dimension and perspectives. Lancet. 2013; 382: 260–272.
13. Damtie S, Biadgo B, Baynes HW, Ambachew S, Melak T, Asmelash D, et al. Chronic kidney disease and associated risk factors assessment among diabetes mellitus patients at a tertiary hospital, Northwest Ethiopia. Ethiopian journal of health sciences. 2018; 28.
14. O'Donoghue DJ. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. Diabetic medicine. 2007; 24: 364-369.
15. Thomas MC, Cooper ME, Zimmet, P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016; 12: 73-81.
16. Mallat SG, Kattar AlS, Tanios BY, Jurjus A. Hyperuricemia, hypertension, and chronic kidney disease: an emerging association. Current hypertension reports. 2016; 18: 1-6.
17. Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. The Lancet. 2018; 392: 2052-2090.
18. Karger AB, Inker LA, Coresh J, Levey AS, Eckfeldt JH. Novel filtration markers for GFR estimation. Ejifcc. 2017; 28: 277.
19. Blaufox MD, Aurell M, Bubeck B, Fommei E, Piepsz A, Russell C, Volterrani D. Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med. 1996; 37: 1883-1890.
20. Wang Y, Levey AS, Inker LA, Jessani S, Bux R, Samad Z, et al.. Performance and determinants of serum creatinine and cystatin C–based GFR estimating equations in South Asians. Kidney international reports, 2021; 6: 962-975.
21. Kazancio?lu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl. 2013; 3: 368-371.
22. Londen VM, Wijninga AB, Vries DJ, Sanders JSF, Jong DMF, Pol RA, et al. Estimated glomerular filtration rate for longitudinal follow-up of living kidney donors. Nephrol Dial Transplant. 2018; 33: 1054-1064.
23. Yue L, Pan B, Shi X, Du X. Comparison between the beta-2 microglobulin-based equation and the CKD-EPI equation for estimating GFR in CKD patients in China: ES-CKD study. Kidney Diseases. 2020; 6: 204-214.
24. Oluyombo R, Ayodele OE, Akinwusi PO, Okunola OO, Gbadegesin BA, Soje MO, et al. Awareness, knowledge and perception of chronic kidney disease in a rural community of South West Nigeria. Niger J Clin Pract. 2016; 19: 161-169.
25. Giavarina D, Husain-Syed F, Ronco C. Clinical implications of the new equation to estimate glomerular filtration rate. Nephron. 2021; 145: 508-512.
26. Li DY, Yin WJ, Yi YH, Zhang BK, Zhao J, Zhu CN, Zuo XC. Development and validation of a more accurate estimating equation for glomerular filtration rate in a Chinese population. Kidney Int. 2019; 95: 636-646.
27. Magee CC, Pascual M. Update in renal transplantation. AMA Arch Intern Med. 2004; 164: 1373-1388.
28. Steubl D, Inker LA. How best to estimate glomerular filtration rate? Novel filtration markers and their application. Curr Opin Nephrol Hypertens. 2018; 27: 398-405.
29. Akbar SA, Zafar SHJ, Marco AA, Beatrice LM, Kostaki GB, Salem R. Complications of renal transplantation. Radiographics. 2005; 25: 1335-1356.
30. Tsujimura K, Ota M, Chinen K, Adachi T, Nagayama K, Oroku M, et al. Cystatin C-based equation does not accurately estimate the glomerular filtration in Japanese living kidney donors. Ann Transplant. 2017; 22: 378-383.
31. Moodley N, Hariparshad S, Peer F, Gounden V. Evaluation of the CKD-EPI creatinine based glomerular filtration rate estimating equation in Black African and Indian adults in KwaZulu-Natal. South Africa. Clin Biochem. 2018; 59: 43-49.
32. Akpan EE, Ekrikpo UE, Udo AIA, Umoh VA, Nkanta AS. Comparability of serum creatinine-Based glomerular filtration rate equations in West African adult communities. Niger J Clin Pract. 2021; 24: 674-674.
33. González GC, Vargas MT, García PK, Contreras K, Rodríguez P. Concordance between estimated glomerular filtration rate using equations and that measured using an imaging method. Revista Medica de Chile. 2021; 149: 13-21.
34. Seliger SL, Davis C, Stehman-Breen C. Gender and the progression of renal disease. Curr Opin Nephrol Hypertens. 2001; 10: 219-225.
35. Zafari N, Churilov L, Wong LL, Lotfaliany M, Hachem M, Kiburg KV, et al. Evaluation of the diagnostic performance of the creatinine?based Chronic Kidney Disease Epidemiology Collaboration equation in people with diabetes: A systematic review. Diabet Med. 2021; 38: e14391.
36. Xie D, Shi H, Xie J, Ding Y, Zhang W, Ni L, et al. A validation study on eGFR equations in Chinese patients with diabetic or non-diabetic CKD. Front Endocrinol, 2019; 10: 581.
37. Bassiony AI, Nassar MK, Shiha O, ElGeidie A, Sabry A. Renal changes and estimation of glomerular filtration rate using different equations in morbidly obese Egyptian patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020; 14: 1187-1193.
38. Silbiger S, Neugarten J. Gender and human chronic renal disease. Gender medicine. 2008; 5: S3-S10.
39. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. The lancet. 2012; 379: 815-822.
40. Feest T. Epidemiology and causes of chronic renal failure. Medicine. 2007; 35: 438-441.
41. Zaki NM, Maghrabi I. Trends in therapeutic interventions in patients with diabetes mellitus in Saudi Arabia. Int J Pharm Pharm Sci. 201; 5: 171-177.
42. Weng H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The lancet. 2016; 388: 1459-1544.